Plasma MicroRNA-21 Predicts Postoperative Pulmonary Complications in Patients Undergoing Pneumoresection
Table 3
Clinical characteristics in patients with and without PPCs.
Variable
No PPCs ()
PPCs ()
value
Age
59.7 ± 5.8
59.6 ± 6.3
0.88
Male (%)
47.3
50
0.75
BMI (mean ± SD)
26.1 ± 2.4
26.3 ± 2.3
0.71
Current smoker (%)
52.1
63.1
0.19
COPD (%)
53.3
39.5
0.11
Hypertension (%)
47.6
60.5
0.13
Heart failure (%)
47.3
31.6
0.06
Diabetes (%)
49.7
63.2
0.12
Surgical procedures (%)
VATS pulmonary lobectomy
10.3
10.5
0.78
VATS segmentectomy
13.9
13.2
0.85
VATS pulmonary wedge resection
21.8
15.8
0.09
Pulmonary lobectomy
26.4
36.8
0.23
Segmentectomy
11.5
13.2
0.78
Pulmonary wedge resection
16.1
10.5
0.26
Operation time: means ± SD (min)
149.9 ± 36.3
160.9 ± 43.6
0.11
Blood loss: mean ± SD (mL)
107.3 ± 27.6
115.8 ± 21.4
0.94
OLV (%)
47.6
68.4
0.02
Continuous data are presented as means ± SD. Numerical data are presented as percentage among designated patient groups. values were derived using 2-sample Student’s -test or Wilcoxon rank-sum test for continuous variables and 2-tailed or Fisher’s exact test for categorical variables. OLV: one-lung ventilation.
